Allworth Financial’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $101K | Buy |
1,538
+108
| +8% | +$7.08K | ﹤0.01% | 1543 |
|
|
2025
Q1 | $94.5K | Hold |
1,430
| – | – | ﹤0.01% | 1251 |
|
|
2024
Q4 | $95.4K | Sell |
1,430
-423
| -23% | -$28.2K | ﹤0.01% | 1280 |
|
|
2024
Q3 | $131K | Buy |
1,853
+159
| +9% | +$11.2K | ﹤0.01% | 958 |
|
|
2024
Q2 | $115K | Buy |
1,694
+156
| +10% | +$10.6K | ﹤0.01% | 1021 |
|
|
2024
Q1 | $104K | Sell |
1,538
-1
| -0.1% | -$68 | ﹤0.01% | 1007 |
|
|
2023
Q4 | $95K | Hold |
1,539
| – | – | ﹤0.01% | 963 |
|
|
2023
Q3 | $90.7K | Hold |
1,539
| – | – | ﹤0.01% | 915 |
|
|
2023
Q2 | $91.8K | Hold |
1,539
| – | – | ﹤0.01% | 921 |
|
|
2023
Q1 | $89.8K | Hold |
1,539
| – | – | ﹤0.01% | 892 |
|
|
2022
Q4 | $95.4K | Hold |
1,539
| – | – | ﹤0.01% | 825 |
|
|
2022
Q3 | $87K | Buy |
1,539
+3
| +0.2% | +$170 | ﹤0.01% | 807 |
|
|
2022
Q2 | $98K | Hold |
1,536
| – | – | ﹤0.01% | 720 |
|
|
2022
Q1 | $99K | Sell |
1,536
-111
| -7% | -$7.15K | ﹤0.01% | 726 |
|
|
2021
Q4 | $110K | Hold |
1,647
| – | – | ﹤0.01% | 661 |
|
|
2021
Q3 | $101K | Buy |
1,647
+567
| +53% | +$34.8K | ﹤0.01% | 614 |
|
|
2021
Q2 | $67K | Hold |
1,080
| – | – | ﹤0.01% | 552 |
|
|
2021
Q1 | $64K | Buy |
+1,080
| New | +$64K | ﹤0.01% | 523 |
|